SynthesisMedicine2017

PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis.

Yu-Ming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.